Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

Reduced-intensity allogeneic stem cell transplantation (RIST) is usually reserved for patients with mantle cell lymphoma who relapse after an autoSCT. However, the long-term efficacy of RIST and its curative potential have not been clearly demonstrated. We studied the long-term outcome of patients r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Robinson, Stephen (VerfasserIn) , Dietrich, Sascha (VerfasserIn) , Dreger, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 January 2018
In: Bone marrow transplantation
Year: 2018, Jahrgang: 53, Heft: 5, Pages: 617-624
ISSN:1476-5365
DOI:10.1038/s41409-017-0067-3
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41409-017-0067-3
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41409-017-0067-3
Volltext
Verfasserangaben:Stephen P. Robinson, Ariane Boumendil, Herve Finel, Karl S. Peggs, Patrice Chevallier, Jorge Sierra, Jürgen Finke, Xavier Poiré, Natacha Maillard, Noël Milpied, Ibrahim Yakoub-Agha, Mickey Koh, Nicolaus Kröger, Arnon Nagler, Yener Koc, Sascha Dietrich, Silvia Montoto, Peter Dreger

MARC

LEADER 00000caa a2200000 c 4500
001 1694461467
003 DE-627
005 20230427095010.0
007 cr uuu---uuuuu
008 200414s2018 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41409-017-0067-3  |2 doi 
035 |a (DE-627)1694461467 
035 |a (DE-599)KXP1694461467 
035 |a (OCoLC)1341314452 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Robinson, Stephen  |e VerfasserIn  |0 (DE-588)1192544889  |0 (DE-627)1671096401  |4 aut 
245 1 0 |a Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma  |b a retrospective study from the EBMT Lymphoma Working Party  |c Stephen P. Robinson, Ariane Boumendil, Herve Finel, Karl S. Peggs, Patrice Chevallier, Jorge Sierra, Jürgen Finke, Xavier Poiré, Natacha Maillard, Noël Milpied, Ibrahim Yakoub-Agha, Mickey Koh, Nicolaus Kröger, Arnon Nagler, Yener Koc, Sascha Dietrich, Silvia Montoto, Peter Dreger 
264 1 |c 15 January 2018 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.04.2020 
520 |a Reduced-intensity allogeneic stem cell transplantation (RIST) is usually reserved for patients with mantle cell lymphoma who relapse after an autoSCT. However, the long-term efficacy of RIST and its curative potential have not been clearly demonstrated. We studied the long-term outcome of patients receiving a RIST for MCL as reported to the EBMT. A total of 324 patients, median age 57 years (range 31-70), underwent a RIST between 2000 and 2008; 43% of the patients had received >3 lines of prior therapy, including an autoSCT in 46%. Non-relapse mortality (NRM) was 10% at 100 days and 24% at 1 year and was lower for patients receiving anti-thymocyte globulin (ATG)/ALG (RR 0.59, p = 0.046). After a median follow-up of 72 months (range 3-159), 118 patients relapsed at a median of 8 months post RIST (range 1-117). The cumulative incidence of relapse was 25% and 40% at 1 and 5 years, respectively, and was associated with chemorefractory disease (HR 0.49, p = 0.01) and the use of CAMPATH (HR 2.59, p = 0.0002). The 4-year progression-free survival rate and overall survival rate was 31 and 40%, respectively. RIST results in long-term disease-free survival in about 30% of the patients, including those patients relapsing after a prior autoSCT. 
700 1 |a Dietrich, Sascha  |d 1979-  |e VerfasserIn  |0 (DE-588)136406300  |0 (DE-627)694354635  |0 (DE-576)301003408  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 53(2018), 5, Seite 617-624  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma a retrospective study from the EBMT Lymphoma Working Party 
773 1 8 |g volume:53  |g year:2018  |g number:5  |g pages:617-624  |g extent:8  |a Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma a retrospective study from the EBMT Lymphoma Working Party 
856 4 0 |u https://doi.org/10.1038/s41409-017-0067-3  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41409-017-0067-3  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200414 
993 |a Article 
994 |a 2018 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 28 
998 |g 136406300  |a Dietrich, Sascha  |m 136406300:Dietrich, Sascha  |d 910000  |d 910100  |e 910000PD136406300  |e 910100PD136406300  |k 0/910000/  |k 1/910000/910100/  |p 16 
999 |a KXP-PPN1694461467  |e 3622973501 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Robinson, Stephen","role":"aut","given":"Stephen","family":"Robinson"},{"role":"aut","given":"Sascha","display":"Dietrich, Sascha","family":"Dietrich"},{"display":"Dreger, Peter","given":"Peter","role":"aut","family":"Dreger"}],"name":{"displayForm":["Stephen P. Robinson, Ariane Boumendil, Herve Finel, Karl S. Peggs, Patrice Chevallier, Jorge Sierra, Jürgen Finke, Xavier Poiré, Natacha Maillard, Noël Milpied, Ibrahim Yakoub-Agha, Mickey Koh, Nicolaus Kröger, Arnon Nagler, Yener Koc, Sascha Dietrich, Silvia Montoto, Peter Dreger"]},"note":["Gesehen am 14.04.2020"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320433366"],"issn":["1476-5365"],"zdb":["2004030-1"]},"disp":"Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma a retrospective study from the EBMT Lymphoma Working PartyBone marrow transplantation","note":["Gesehen am 17.01.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320433366","origin":[{"dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","publisherPlace":"London ; Basingstoke ; London"}],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"part":{"volume":"53","text":"53(2018), 5, Seite 617-624","year":"2018","issue":"5","extent":"8","pages":"617-624"},"language":["eng"],"pubHistory":["Nachgewiesen 19.1997 -"]}],"physDesc":[{"extent":"8 S."}],"id":{"eki":["1694461467"],"doi":["10.1038/s41409-017-0067-3"]},"recId":"1694461467","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"15 January 2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma","subtitle":"a retrospective study from the EBMT Lymphoma Working Party","title":"Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma"}]} 
SRT |a ROBINSONSTLONGTERMOU1520